News and Trends 11 Jul 2022 Treatment for cancer-associated thrombosis fast-tracked by FDA …relative to open label rivaroxaban on the rate of major or clinically relevant non-major (CRNM) bleeding events in patients with atrial fibrillation who are at moderate-to-high risk of stroke. The… July 11, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 16 Dec 2022 CSL closer to gene therapy treatments for hemophilia B patients in Europe …to be generally well-tolerated with no serious treatment-related adverse events. The positive opinion from the CHMP will now be reviewed by the European Commission, which has the authority to approve… December 16, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
More News! 1 Mar 2018 Just a Single Dose of this Drug Boosts the Survival of Heart Failure Patients …weak.” As this process is implicated in 80% of heart failure cases, the biotech has targeted this aspect of the disease. Berlin Cures’ drug prevents antibodies from damaging the heart…. March 1, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 17 Jul 2017 A Brand New Outlook on Induced Pluripotent Stem Cells …allow essential nutrients in and insulin out. It prevents access of host immune cells and subsequently the destruction of the newly implanted cells. Scientists are now focusing on multicellular systems… July 17, 2017 - 8 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 9 Aug 2022 Asthma in the spotlight as Upstream Bio starts trial and UK universities propose new long-term treatment …activation is one of the first events in the inflammatory cascade stimulated by allergens, viruses, and other triggers, initiating the upregulation of downstream targets such as IL-4, IL-5, IL-13, IL-17… August 9, 2022 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 17 Dec 2018 Novo Nordisk Partners Dutch Biotech to Prevent Cardiovascular Disease …also cut the frequency of major cardiovascular events by over 20% compared with placebo. Furthermore, Novo recently launched a collaboration with fellow Danish company Embark Biotech, with the aim of… December 17, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jul 2025 XOMA Royalty’s acquisition of Turnstone Biologics: what do royalty deals offer the biopharma industry? …to make up to $25 million in milestone payments. In addition, XOMA Royalty will make success-based payments on future development and commercial events to Pulmokine stockholders, it said in the… July 11, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 3 Mar 2020 Alnylam Gets Second RNAi Drug Approval from EMA …blood, around the body. Patients normally have a genetic mutation in one of the genes that make heme – a key component of hemoglobin in the blood. This prevents them… March 3, 2020 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 15 Nov 2022 Aelis Farma’s first trial for cognitive disorder drug for Down Syndrome patients …and 55 years old. The results obtained have shown that all the doses of AEF0217 were well tolerated by healthy volunteers with no serious adverse reaction. Only three adverse events… November 15, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 16 Dec 2022 Astellas gastric cancer drug meets phase 3 primary endpoint …frequent treatment-emergent adverse events (TEAEs) were nausea and vomiting. Detailed results will be presented at a future scientific congress and submitted for publication. An important milestone in Astellas’ gastric cancer… December 16, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 11 Apr 2023 Calida Therapeutics launches to tackle thrombo-inflammatory disorders …cross-talk between platelets and myeloid cells, thus abolishing the chain reaction of these two phenomena which can lead to tissue damage and life-threatening events.” “Inflammation can now also be seen… April 11, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 20 Jul 2023 Endometrial cancer drug receives breakthrough therapy designation in China …safety of fruquintinib in combination with sintilimab. Entry criteria include those endometrial cancer patients who experienced disease recurrence, disease progression or grade 3 or higher serious adverse events with treatment… July 20, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email